Switch to:
GuruFocus has detected 1 Warning Sign with Valeant Pharmaceuticals International Inc $VRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash Flow from Others
$1,810 Mil (TTM As of Dec. 2016)

Valeant Pharmaceuticals International Inc's cash flow from others for the three months ended in Dec. 2016 was $645 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2016 was $1,810 Mil.


Definition

Valeant Pharmaceuticals International Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2016 was 96.7 (Mar. 2016 ) + -35.6 (Jun. 2016 ) + 1103.5 (Sep. 2016 ) + 645.4 (Dec. 2016 ) = $1,810 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others 93-60561961342937392937661,810

Valeant Pharmaceuticals International Inc Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Cash Flow from Others -12528912114919927597-361,104645
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK